Aquestive therapeutics reports third quarter 2021 financial results, provides business update and improves full year guidance

Warren, n.j., nov. 02, 2021 (globe newswire) -- aquestive therapeutics, inc. (nasdaq:aqst), a pharmaceutical company focused on developing and commercializing differentiated products that address patients' unmet needs and solve therapeutic problems, today reported financial results for the third quarter ended september 30, 2021 and provided an update on recent developments in its business.
AQST Ratings Summary
AQST Quant Ranking